ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
29 Mayo 2024 - 3:30PM
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today
announced that Nikhil Lalwani, Chief Executive Officer, will
present at the 2024 Jefferies Global Healthcare Conference in New
York City as follows:
Date: |
June 5,
2024 |
|
|
Time: |
4:30 ET |
|
|
Webcast: |
Click Here |
|
|
To schedule a 1x1 meeting with the Company, please contact your
Jefferies representative.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified
biopharmaceutical company serving patients in need by developing,
manufacturing, and marketing high-quality branded and generic
prescription pharmaceutical products, including for diseases with
high unmet medical need. The Company is focused on delivering
sustainable growth by scaling up its Rare Disease business through
its lead asset Purified Cortrophin® Gel, strengthening its Generics
business with enhanced research and development capabilities,
delivering innovation in Established Brands, and leveraging its
U.S. based manufacturing footprint. For more information, please
visit our website www.anipharmaceuticals.com.
Investor Relations: Lisa M. Wilson,
In-Site Communications, Inc.
T: 212-452-2793 E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals (NASDAQ:ANIP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024